Log In
Print
BCIQ
Print
Print this Print this
 

GM-CT-01 (formerly Davanat)

  Manage Alerts
Collapse Summary General Information
Company Galectin Therapeutics Inc.
DescriptionPolysaccharide in a carbosome formulation that targets specific lectin receptors on cancer cells
Molecular Target Galectin-3 (LGALS3) ; Galectin-1 (LGALS1)
Mechanism of ActionGalectin-3 antagonist
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today